employees have found that using a special type of drug called a biologic monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of shimmer therapy for lung cancer profession ? pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life, according to regulation to regulation to a study presented at the Plenary I session on October 29, 2007, at the stars and bars Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

More: - From the site